Home Page Link AgBioWorld Home Page
About AgBioWorld Donations Ag-Biotech News Declaration Supporting Agricultural Biotechnology Ag-biotech Info Experts on Agricultural Biotechnology Contact Links Subscribe to AgBioView Home Page

AgBioView Archives

A daily collection of news and commentaries on
ag-biotech.


Subscribe AgBioView Read Archives

Subscribe AgBioView Subscribe

Search AgBioWorld Search Site

Prakash Interviews

AgBioWorld Articles

Other Articles

Biotech and Religion

Media Contacts

Press Releases

Special Topics

Spanish Articles


 

Policies Toward GM Crops In India cont.,

IV. Trade Policy

Since GM crops are politically controversial in India, the government is under pressure from NGOs to impose a GM-free trade policy requirement on the nation's commodity imports and exports. So long as no GM crops are being planted within India on biosafety grounds, such an official GM-free trade policy can be relatively easy for the government to embrace and implement. A policy of standing aloof from international GM commodity trade is also relatively easy to embrace in India because the nation has, for decades, tended to stand somewhat aloof from all international food commodity trade in its official pursuit of "national food self-sufficiency." Ever since India's bad experience with excessive dependence on international food aid in the 1960s, political leaders have sought to avoid not only renewed concessional dependence on world markets, but commercial dependence as well.

India’s policy aversion to international food trade of all kinds is reflected in the fact that the nation has recently accounted for roughly 10 percent of total world agricultural production, but less than 1 percent of world commodity trade (Sharma 2000). With continued income growth in India, demand for imported grains is likely to grow, yet actual imports will continue to be slowed by significant trade barriers at the border. As one example, India recently imposed an 80 percent duty on rice to curb the influx of what it called "cheap grain." India occasionally imports small quantities of corn, but it strictly controls these imports with a tariff rate quota imposing a 60 percent duty on imports larger than the quota. In the case of wheat, India allows imports only in rare cases to offset specific internal transport cost problems, for example to allow some less expensive imported wheat to reach some coastal flour mills in the southern part of the country. India also exports very little wheat, despite its occasionally large internal surplus stocks. In 2000, when India's excess wheat stocks reached 27 million tons, efforts were finally made to clear the stocks through export, yet these were frustrated in part by the known presence of a wheat crop disease - "Karnal Bunt" fungus - in some parts of India, which has put wheat from India on the import ban list of some thirty other countries (APBN 2000a).

Given these larger aversions in India to free international food commodity trade, and given the absence so far of any GM crop production within India itself, imposing an effective ban on the import and export of GM commodities has been easy enough for the Indian government to manage. Under India's official GM Guidelines it is GEAC which must approve any large scale import of GM commodities, and so long as GEAC has not approved the commercial planting of GM crops at home it may naturally wish to go slow on approval of commercial imports from abroad. Politicians in India will resist GM crop imports as well. Ever since the 1998 controversy over field trials for Monsanto’s Bt cotton, government ministers have routinely defended themselves with statements that GM foods are not being grown or imported into India, and will not be imported without proper safeguards.

India's official GM crop import ban was tested under unusual circumstances in the summer of 1998, when the nation experienced a highly publicized food safety emergency unrelated to GM crops. More than 50 people in Delhi died after eating a contaminated locally grown (and non-GM) mustard oil, the most popular cooking oil in northern India. The government acted by banning sales of mustard oil pending safer packaging. To make up the shortage, it had to authorize temporary imports of soybeans and lower its import duties on soybean oil (Wall Street Journal, December 8, 1998, p. A10). Anti-trade and anti-GM NGO leaders responded to this action with a letter to the Prime Minister, alerting him to the fact that some of the soybeans about to be imported could be GM. The government sought to finesse the issue on this occasion by arranging to import soybeans that were already split and hence suited only for oil production, and not planting. Because the soybeans were not intended for environmental release and since they were not explicitly labeled GM, the Government on this occasion managed to avoid seeking formal import approval from GEAC. In the future it may be more difficult for the Government of India to avoid engaging GEAC in approval of bulk commodity imports. The January 2000 Biosafety Protocol obliges exporters (under Article 18) when shipping LMOs internationally to label those shipments as "may contain LMOs" and "not intended for intentional introduction into the environment." Identifications of this kind are more likely to trigger a mandatory review in India by GEAC, or at least more vigorous complaints by NGOs if GEAC is again avoided. NGOs in India opposed to GM crops and foods can take extreme positions on the import question. In June 2000, RFSTE reacted with outrage when it learned that some of the corn-soya blend food aid that was being imported via CARE and CRS to provide relief to Indian victims of a super cyclone in the Eastern coastal state of Orissa, had come from the United States and was thus likely to be "genetically contaminated." RFSTE castigated the United States for "using the Orissa victims as guinea pigs for GE products" and called on the government of India to explore alternative sources of food aid (RFSTE 2000).

India’s policy regarding imports of GM germplasm for research purposes has so far been permissive rather than preventive. Some extra steps are required when importing GM materials for research, and some bureaucratic delays are encountered, but the imports themselves have never been held back. This partly reflects the fact that RCGM, rather than GEAC, has final authority to clear transgenic imports for research purposes (DBT 1998, p. 8). Technically, any importer of GM germplasm must also get phyto-sanitary clearance from India’s relevant quarantine authority, the National Bureau of Plant Genetic Resources (NBPGR), yet NBPGR typically acts on the recommendation of RCGM and conducts a phyto-sanitary evaluation, as a routine precaution against import of diseased or infested materials.5 RCGM is a committee dominated by representatives from the government institutes doing some of the research, so its permissive stance on imports is not surprising, yet private companies as well have had little trouble bringing GM materials into the country if the purpose is research only.

The import decision process in India is prone to a jurisdictional dispute between RCGM and GEAC, similar to that discussed earlier in the case of field trials. RCGM is authorized to approve small scale imports only, and GEAC alone can approve large scale imports, but there is not yet a clear definition of the dividing line between the two. Tiny quantities of 10 kg or less have until now fallen clearly under RCGM's jurisdiction, but a potential for conflict over larger shipments remains. India's Guidelines document empowers GEAC to give approval or disapproval (from an environmental vantage point) of all large scale "import, export, transport, manufacture, process, [or] selling of any microorganisms or genetically engineered substances or cells including food stuffs..." (DBT 1990 p. 17) The encompassing language of this provision again suggests how little the Government of India has been willing to entrust this new technology to private sector market forces alone, let alone international market forces.

In export markets, India has on occasion faced a temptation to use its GM-free status to seek price premiums. India is a small exporter of soybean meal (1.5-2.2 million tons per year, in recent years), and it has recently promoted these meal exports (also sunflower meal and rapeseed meal) as "GM free" for sale to overseas markets, such as Japan, Indonesia, Thailand, the Philippines, the Gulf countries, and the Middle East (APBN 2000b). Yet most of these sales are for animal feed purposes, so price premiums have been difficult to secure. Indian meal exporters have nonetheless begun hoping that Asian countries such as Thailand, because they export chickens to the GM-conscious European market, will soon see the advantage of taking feed imports from a GM-free supplier such as India, rather than from nations that plant GM crops such as the United States.

India can thus be classified as embracing a trade policy toward GM crops which is fully "preventive" by the definition in use here: a de facto blockage on GM commodity imports, coupled with occasional efforts to use the nation's GM free status to seek premiums in export markets. The strength of this policy will be tested if and when GM crops are finally given biosafety approval for planting by Indian farmers, particularly food crops (not just cotton). At this point the nation's overall GM free status will disappear, so costly internal market segregation and labeling procedures will be required in order to offer GM free guarantees to foreign customers. Avoiding these costly trade-linked procedures could become an additional reason for India's GEAC to go slow on the final approval of internationally traded GM food crops for planting by India's farmers.


5. NBPGR has been responsible for developing testing procedures to detect the presence or absence of GM materials in imports, and India's Ministry of Commerce is now partially responsible as well for monitoring imports for GM content.

Previous Next